Document is current
Any future updates will be listed below
-
Authors
Tremain, Andrew C.
Wallace, Rachel P. https://orcid.org/0000-0003-4439-1173
Lorentz, Kristen M.
Thornley, Thomas B.
Antane, Jennifer T.
Raczy, Michal R.
Reda, Joseph W. https://orcid.org/0000-0002-9413-5111
Alpar, Aaron T. https://orcid.org/0000-0003-4669-4813
Slezak, Anna J.
Watkins, Elyse A. https://orcid.org/0000-0003-2691-5930
Maulloo, Chitavi D.
Budina, Erica
Solanki, Ani
Nguyen, Mindy
Bischoff, David J.
Harrington, Jamie L.
Mishra, Rabinarayan
Conley, Gregory P.
Marlin, Romain https://orcid.org/0000-0001-8932-0171
Dereuddre-Bosquet, Nathalie
Gallouët, Anne-Sophie
LeGrand, Roger
Wilson, D. Scott https://orcid.org/0000-0001-8029-1036
Kontos, Stephan
Hubbell, Jeffrey A. https://orcid.org/0000-0003-0276-5456
- License Information
-
More Information
Article History
Received: 23 August 2022
Accepted: 2 August 2023
First Online: 7 September 2023
Competing interests
: This work was funded in part by Anokion SA. D.S.W., J.A.H., S.K. and K.M.L. are inventors on patents related to synthetically glycosylated antigens, licensed to Anokion SA. J.A.H. consults for Anokion, is on the Board of Directors of the company and on its Scientific Advisory Board, and holds equity in the company. T.B.T., D.J.B., J.L.H., R.M., and G.P.C. are employees of Anokion. S.K. is on the Scientific Advisory Board of Anokion and holds equity in the company. K.M.L. also holds equity in Anokion. All other authors declare no competing interests.
